<DOC>
	<DOCNO>NCT01132417</DOCNO>
	<brief_summary>Observational : study human being biomedical and/or health outcome assess pre-defined group individual . Subjects study may receive diagnostic , therapeutic , intervention , investigator assign specific intervention subject study .</brief_summary>
	<brief_title>In Vitro Activity Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance</brief_title>
	<detailed_description>Study Phase Definition : Phase investigation , define US FDA trial involve investigational new drug . Select one . N/A : trial without phase Observational Study Design Case-control : group individual specific characteristic ( e.g. , condition exposure ) compare group ( ) different Time Perspective Cross-sectional : observation measurement make single point time , usually subject enrollment Biospecimen Retention - select one Samples Without DNA - sample retain , potential DNA extraction retain sample ( e.g. , fix tissue , plasma ) Biospecimen Description Sputum , whole blood , urine , tissue Enrollment Single group study Number Groups/Cohorts Definition : Number study groups/cohorts . Enter 1 single-group study . Many observational study one group/cohort ; case control study typically two . One study group , anticipate sample ring 400-500 sample 8 . Arms , Groups Interventions N/L Group/Cohort Label</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>All patient infection MDRs infection include</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Tigecycline , MDR</keyword>
	<keyword>Patient infect multidrug resistance bacteria</keyword>
</DOC>